1 / 75

Antibiotics and Steroids in Ophthalmic Practice

Learn about the various antibiotics and steroids used in ophthalmic practice, their mechanisms of action, effects, and side effects. Explore the drug treatment of certain diseases.

thomaslittle
Download Presentation

Antibiotics and Steroids in Ophthalmic Practice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. O , my sustainer! Open my Heartandmake my task easy for meand loosen the knot from my tongueso that, they might understand my speechSurahTaha (16:25-290)____Al Quran

  2. ANTIBOITICS , STEROIDS USED IN OPHTHALMIC PRACTICE AND DRUG TREATMENT OF CERTAIN DISEASES Dr. Faizur RahmanProfessor of OphthalmolgyPeshawar Medical CollegePeshawar

  3. Learning objectives At the end of the session the students would be able to: • Know various antibiotics and steroids used in Ophthalmic practice. • Describe the rationale of using various drugs. • Mechanism of action , effects and side effects of these drugs. • Know drug treatment of certain diseases

  4. What is antibiotic? • A chemical substance produced by one organism causing the death of other bacterial cells i.e penecillin and streptomycin. • After the introduction of synthetic agents these are now called antibacterials. • As newer agents came up now a wide spectrum of drugs are available called antimicrobials.

  5. Mechanism of action. • Difference between humans and microbes is exploited to produce substances toxic to microbes and harmless to humans. • The selective toxicity may be relative than absolute. • Concentration of antimicrobials must be carefully controlled.

  6. Mechanism of action...Cont. • INHIBIT BACTERIAL CELL WALL OR ACTIVATE ENZYMES THAT DESTROY BACTERIAL CELL WALL: • PENICILLINS • CEPHALOSPORINS • BACITRACIN • VANCOMYCIN • KETOCONAZOLE • MICONAZOLE

  7. Mechanism of action...Cont. • ALTER CELL WALL PERMEABILITY AND LEAKAGE OF INTRACELLULAR CONTENTS • POLYMYXINS • NYSTATIN • AMPHOTERICIN B • COLISTIMETHATE

  8. Mechanism of action...Cont. • INHIBIT PROTEIN SYNTHESIS • Tetracyclines • Aminoglycosides • Macrolides/Ketolides • Clindamycin • Chloramphenicol

  9. Mechanism of action...Cont. • DRUGS THAT BLOCK SPECIFIC METABOLIC STEPS (Foleate inhibitors) • SULFONAMIDES • TRIMETHOPRIM • INHIBIT DNA DEPENDENT RNA POLYMERASE • RIFAMPICIN

  10. Mechanism of action...Cont. • INHIBIT DNA DEPENDENT DNA SYNTHESIS • QUINOLONES • ACT AS NUCLEIC ACID ANALOGUES • ANTIVIRALS

  11. Selection. • Identify the infecting organism • Empiric therapy prior to identification • Determination of susceptibility • Barriers • Patient factors. • Safety of agent • Cost of therapy.

  12. Common Antimicrobials used in Ophthalmology • Chloramphenicol (Topical) • Anti-mycotics(Systemic and topical) • Aminoglycosides(Systemic and topical) • Sulphonamides(Systemic and topical) • Anti-virals (Systemic and topical) • Macrolides(Systemic) • Quinilones (Systemic and topical) • Cephalosporines (Systemic and topical)

  13. Ophthalmic Antibiotics

  14. STEROIDS

  15. Types • Mineralo corticoids • Glucocorticoids • Androgens

  16. Some Corticosteroids • Beciomethasone • Betamethasone • Cortisone • Des oxy cortico sterone • Dexamethasone • Fludro cortisone • Hydrocortisone • Methyl prednisolone • Para methasone • Prednisolone • Prednisone • Triamcinolone

  17. Actions • Promote normal intermediary metabolism: Gluconeogenesis Stimulate protein catabolism Stimulate lipolysis • Increase resistance to stress by: Raising blood glucose level Modest rise in BP • Alter blood cell levels in plasma: Decrease in eosinophils, basophils, monocytes and lymphocytes by redistribution from circulation to lymphoid tissue Increase in the number of RBC, platelets, neutrophils

  18. Actions…Cont. • Anti inflammatory action: (Complex mechanism) Suppression of immunity Indirect inhibition of phospholipase A2 • Alter other endocrine systems: Decrease in ACTH and TSH Increase in GH • Effects on other systems: Increased production of gastric acid, pepsin Effects on CNS Bone loss Myopathy

  19. Indications • In the treatment of ocular inflammations and immune related ocular diseases. • Act by suppressing the formation of arachidonic acid and other mediators by induction mediators like phospholipaze A2 and inhibitory protein Lipocorteins • Prevent edema, Fibrin deposition, capillary dilatation and proliferation, Leukocyte infiltration and subsequent scarring.

  20. Antibiotic + Steroid Preparations

  21. Properties and Duration of action • Long acting/ Short acting/ Depot • Very potent • Potent • Moderately potent • Mild

  22. Side effects-Systemic • Impaired wound healing/ Easy Bruising • Negative calcium balance/ Osteoporosis • Increased appetite/ Hyperglycemia/ Diabetes Mellitus • Euphoria/ Depression/ Psychosis • Hypertension • Edema (Sodium and water retension)/ Weight Gain • Peptic ulcers/ GI Hemorrhage/ GI Perforation • Hypokalaemia (Potassium depletion) • Hirsutism /Acne/ Coetaneous striae/ Amenorrhea • Myopathy (Gluconeogenesis) • Avascular Bone necrosis (Neck of femur) • Decreased Immunity

  23. Side effects- Eye • Cataract (PSC) • Steroid induced Glaucoma • Retinal Micro-Aneurysms • Papilloedema • Delayed Wound Healing • Mild Blephroptosis • Immune Suppression-Secondary Infections • CANDIDA, TOXOPLASMOSIS, CMV, HSV,

  24. Routes of administration • Topical • Intralesional • Subconjunctival • Subtenon • Periocular • Intravitral • Intracameral • Systemic oral iv

  25. Commonly used Steroids • Prenisolone (Topical and systemic) • Dexamethasone (Topical and systemic) • Betamethasone (Topical and systemic) • Hydrocortisone (Systemic only) • Loteprednol (Topical only) ( No IOP Rise) • Flouromethalone (Topical only) ( No IOP Rise)

  26. Steroid use in ophthalmology • Intra lesional in hemangioma and chalazion • Iv in optic neurirtis • Oral in dysthyroid ophthalmopathy. Corneal transplant • Intravitreal in CRVO • Topical postoperative, uveitis, corneal transplant • Intracameral Per-op in children

  27. Strong Steroids

  28. Weak Steroids

  29. DexamethasoneInjectios and Prednisole Tablets

  30. Hydrocortisone and PrednisoloneInjections

  31. Steroid Drops

  32. Treatment of Orbital Cellulitis • The patient with orbital cellulitis should be promptly hospitalized for treatment. Hospitalization should be continued until the patient is afebrile and is clearly improved clinically. • Symptomatic; antipyretic, NSAIDS • Antimicrobials ; • Ceftazidime 1 g tds , I/M • Metronidazole 500mg tds, PO • Vancomycin in case of allergy to the above mentioned • Surgical intervention in case of local abscess or unresponsive cases • Consultation with ENT specialist, neurosurgeon & paediatrician if required

  33. Treatment of Orbital Cellulitis • Specifically identified pathogens identified on cultures. • Intravenous antibiotic therapy should be continued for 1-2 weeks and then followed by oral antibiotics for an additional 2-3 weeks. • Fungal infection requires intravenous antifungal therapy along with surgical debridement.

  34. Treatment of Orbital Cellulitis Surgical drainage of an orbital abscess is indicated if any of the following occurs: • A decrease in vision occurs. • An afferent pupillary defect develops. • Proptosis progresses despite appropriate antibiotic therapy. • The size of the abscess does not reduce on CT scan within 48-72 hours after appropriate antibiotics have been administered. • If brain abscesses develop and do not respond to antibiotic therapy, craniotomy is indicated.

  35. Treatment of Trachomatous Conjunctivitis SAFE strategy developed by WHO for trachoma: • Surgery: • To prevent blindness & limits progression of corneal scarring. • Can improve vision. • Antibiotics: • Azithromycin—1 G single dose (adults). • Children: 20mg/kg single dose

  36. Treatment of Trachomatous Conjunctivitis • Erythromycin 250 mg QID for 4 weeks. (children 125mg/kg). • Tetracycline 250 mg QID for 4 weeks. • Topical tetracycline 1% 0.5 inch ribbon BD for 6 weeks. • Facial cleanliness: • Reduces risk & severity of trachoma. • Environmental change: • Improved water supply & household sanitation. • Personal & community hygiene. • Adequate housing & water & sewage system.

  37. Ophthalmianeonatorum • Topical Tetracycline. • Oral Erythromycin 25mg/kg body weight 12 hourly for 14 days. Caution: Examine mother & father for chlamydialurethritis/ cervicitis and treat.

  38. Acute Dacrocystitis • Broad spectrum antibiotics • Analgesics • Drainage if abscess formation

  39. Treatment of Corneal Ulcer (Bacterial) • Initial treatment: Broad spectrum topical antibiotics (Fortified) • Dual therapy: Aminoglycoside & cephalosporin. • Mono therapy: Fluoroquinolone. • Oral antibiotics: • Atropine. • Systemic analgesics.

  40. Treatment of Corneal Ulcer (Viral) • Acyclovir 3% ointment x 5 times daily • Trifluorothymidine 1% drops 2-hourly • Debridement if non-compliance or no response

  41. Treatment of Corneal Ulcer (Fungal) • Polyenes: Natamycin 5%: Filamentous fungi. Amphotericin B: Filamentous fungi. • Imidazole: Miconazole 1%: Candida, Aspergillus. Systemic: Itraconazole, Ketoconazole. • Pyramidine: Flucytosine 1%: Candida.

  42. Antifungal (Natamycin)

  43. Treatment of Corneal Ulcer (Acantamoebal) • Topical: Propamidine Isothionate 0.1% (Brolene), Dibromopropamidine Isothionate 0.15%, Miconazole 1%. • Systemic: Ketoconazole.

  44. Treatment of Endophthalmitis • Intravitreal antiboitics • Subconjuntival antibiotics. • Topical antibiotics. • Role of systemic antibiotics. • Role of steroids. • Role of vitrectomy. • Cycloplegics and analgesics.

  45. Drug Treatment of Glaucoma

  46. PRIMARY GOAL To prevent further damage to the eye by lowering IOP & to ultimately prevent blindness

  47. Systemic-Used in Emergency • Plasma Expanders • Urea • Mannitol 20% IV solution. Dose: 1-2g/kg or 5 ml/kg body weight. Up-to 60 drops/min over 20-30 min. Peak of action: within 30 min. Duration of action: up-to 6 hrs. • Diuretics • IV Acetazolimide

  48. Glycerol-Oral • 50% solution. • Oral agent with a sweet & sickly taste. • Pure lemon should be added to avoid nausea. • Dose:1-2g/kg or 2-4ml/kg body weight. • Peak of action: Within 1 hr. • Duration of action: Upto 3 hrs. • Metabolized to glucose in the body.

  49. Isosorbide-Oral • Oral agent with a minty taste. • Dose: Same as for glycerol. • Metabolically inert & can be given to diabetics without insulin cover.

More Related